Haemodialysis Tunisian patient with acquired factor V inhibitor associated to arteriovenous shunt thrombosis
| Autor: | Wijdene El Borgi, Ikbel Ghachem, Fatma Ben Lakhal, Emna Gouider, Iheb Ghiriani, Amel Chelbi, Sarra Fekih Salem |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty Tunisia Factor V Deficiency medicine.medical_treatment Factor V inhibitor Gastroenterology Arteriovenous Shunt Surgical Postoperative Complications Renal Dialysis Internal medicine medicine Humans Renal Insufficiency Chronic Aged Autoantibodies business.industry Antibiotic exposure Autoantibody Factor V Thrombosis General Medicine Blood Coagulation Disorders medicine.disease Arteriovenous shunt thrombosis Hemodialysis business |
| Zdroj: | Annales de Biologie Clinique. 78:206-209 |
| ISSN: | 0003-3898 |
| DOI: | 10.1684/abc.2020.1540 |
| Popis: | Factor V deficiency is a rare hemostatic disorder. It may present with a diverse spectrum of symptoms due to a variety of mechanisms including development of autoantibodies associated with a number of conditions. We report a first case of factor V deficiency in Tunisian hemodialysis patient due to an autoantibody most likely secondary to antibiotic exposure responsible for an arteriovenous shunt thrombosis rather than bleeding. We discuss here the clinical and biological features of acquired factor V inhibitor and provide a short review of the current literature. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|